ARTICLE | Company News
Eli Lilly sales and marketing update
October 5, 2015 7:00 AM UTC
The U.K.’s NICE issued preliminary draft recommending against Cyramza ramucirumab from Eli Lilly to treat advanced gastric cancer or gastro-esophageal junction adenocarcinoma previously treated with ...